Evaluation of protective effects of methylene blue on cisplatin-induced nephrotoxicity. (2022)

Peer-Reviewed Study · Usefzay O, Yari S, Amiri P, Hasanein P · April 25, 2022

Usefzay O et al., 2022-04-25: Rat study finding intraperitoneal methylene blue 4 mg/kg for seven days reduced cisplatin-induced kidney injury markers and histological damage.

The results showed that the MB (4 mg/kg) + CP treated rats underwent a lesser weight loss compared to the CP group

Usefzay O et al., 2022-04-25: Rat study finding intraperitoneal methylene blue 4 mg/kg for seven days reduced cisplatin-induced kidney injury markers and histological damage. C10 (renal protection, animal). Study type: animal experiment, 28 male rats in 4 groups; Hamadan University of Medical Sciences, Iran (per the authors' affiliation in the record). Dose: single cisplatin 5 mg/kg then methylene blue 4 mg/kg intraperitoneally for 7 days. Comparator: cisplatin alone. Funder/conflicts not stated in the abstract. This is an animal study and cannot support a human renal-protection claim; recorded as SUPPORTS of the claim's existence, MEDIUM confidence because the abstract gives only part of the result set. Biomed Pharmacother 2022;150:113023. Study type: animal.